Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,365,632
-
Total 13F shares
-
40,775,249
-
Share change
-
-496,922
-
Total reported value
-
$704,191,848
-
Price per share
-
$17.27
-
Number of holders
-
103
-
Value change
-
-$8,659,480
-
Number of buys
-
56
-
Number of sells
-
32
Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2022
As of 30 Sep 2022,
Replimune Group, Inc. - COMMON STOCK (REPL) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,775,249 shares.
The largest 10 holders included
Omega Fund Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, Redmile Group, LLC, Atlas Venture Life Science Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, T. Rowe Price Investment Management, Inc., and EMERALD ADVISERS, LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.